Nowo: Cobertura 2021

Access to Novo Nordisk’s portfolio is currently defined by a binary distinction: those with Diabetes generally have coverage, while those seeking treatment for Obesity face significant financial barriers. The paradigm is shifting as obesity is increasingly recognized as a chronic metabolic disease rather than a lifestyle choice. However, until list prices decrease or legislation mandates coverage, "cobertura" will remain the primary hurdle for patients seeking these therapies.

" Cobertura" is the Spanish and Portuguese word for "insurance coverage." Therefore, this paper will focus on the evolving landscape of , analyzing the tension between high demand, limited supply, and insurance reimbursement hurdles. nowo cobertura

The most critical factor in determining coverage ("cobertura") is the diagnosis code submitted by the prescribing physician. Access to Novo Nordisk’s portfolio is currently defined